Patterns of eating behavior in people with severe obesity seeking weight loss treatment: An exploratory study.

Although subjects with severe obesity need specific interventions, knowledge about their eating behavior, physical and mental health profiles remains insufficient. This cross-sectional study aimed to identify profiles of individuals with severe obesity based on clinical, psychological and eating behavior characteristics. We included 126 participants (103 women; mean age: 47.2 ± 13.9 years; mean BMI: 41.0 ± 5.7 kg/m2). Cluster analyses were performed to identify profiles based on age, waist circumference, eating behavior, depressive symptoms, food-related quality of life and physical activity. Metabolic syndrome components and type 2 diabetes prevalence were compared between the clusters. Three clusters were identified. Cluster 1 labeled struggling with food (48% of the population) had high scores on both emotional eating and uncontrolled eating, low score on comfort with food and they had depressive symptoms. Cluster 2, low loss of eating control (29%), had low scores on emotional eating and uncontrolled eating, and high quality of life in the psychosocial dimension. Cluster 3, pleasure from eating (22%), had the greatest score on comfort with food, the highest physical activity level, and depressive symptoms. In cluster 2, prevalence of type 2 diabetes was higher, although not statistically significant. Otherwise, no differences were found between clusters. Conclusion: Subjects with severe obesity have different profiles, partly explained by their eating behavior, associated with clinical and behavioral patterns. Further studies should confirm this cluster structure and assess how these profiles impact the evolution of obesity and whether they can help to improve the personalization of care programs.

Emerging challenges to realizing global polio eradication and their solutions.

Background: The Global Polio Eradication Initiative (GPEI) promised to eradicate polio by 2000, yet the disease remains endemic in 2 countries. The current threat of resurgence in countries with low vaccine coverage and circulating vaccinederived poliovirus (cVDPV) outbreaks due to oral polio vaccine warrants a strategy review. Aims: To review the performance of the GPEI from a context based in Pakistan, identifying threats to success and suggesting strategy modifications to help achieve eradication. Methods: This was a desk review of the effectiveness of GPEI that was launched in 1988 to eradicate polio by 2000. Subsequent failure to eradicate led to multiple iterations in strategy and planning documents. These documents were reviewed alongside relevant literature to explore the reasons for failure and emergence of cVDPV. Results: GPEI has been effective in reducing the global polio disease burden by > 99%, but it remains endemic in Pakistan and Afghanistan. cVDPV has caused multiple outbreaks since 2000, and caused 7 times more cases than wild poliovirus (WPV) globally in 2020. The Polio Eradication and Endgame Strategic Plan 2013-2018 aimed to eradicate WPV and cVDPV simultaneously. In 2019, Pakistan saw an upsurge in WPV amid an outbreak of cVDPV infection that continued throughout 2020. Wild polio eradication was not realized and the country was unable to transition to inactivated polio vaccine as predicted in the strategic plan. Conclusion: Over 20 countries now report cVDPV outbreaks and many others are at risk. A country-specific modified strategy is required to eradicate WPV and cVDPV simultaneously, more so in endemic countries.

Synthetic Zeolite Supplementation as a Potential Candidate for the Therapy of Diabetic Syndrome.

<b>Background and Objective:</b> Natural and Synthetic Zeolite (SZ) is potentially useful for biopharmaceuticals and bio tools due to its unique and outstanding physical and chemical properties. Thus, the present study aimed to evaluate the possible effect of synthetic zeolite in (STZ)-induced diabetic rats. <b>Materials and Methods:</b> About 4 groups of rats were used, (I) normal control, (II) SZ group, (300 mg/kg/day), (III) STZ group, diabetic rats acted as positive control and (IV) STZ+SZ group, included diabetic rats treated with synthetic zeolite (300 mg/kg/day), statistical analysis comparisons between means were carried out using one-way analysis of variance (ANOVA) followed by a post hock (Tukey) multiple comparisons test at p<u>></u>0.05. <b>Results:</b> After six weeks, treatment of diabetic animals with synthetic zeolite markedly exhibited a significant reduction in glucose, lipids, DNA fragmentation, Alanine Aminotransferase (ALAT), Aspartate Aminotransferase (ASAT), urea, creatinine, Malondialdehyde (MDA) and Nitric Oxide (NO) levels concomitant with a significant rise in insulin, Glutathione (GSH), Superoxide Dismutase (SOD) and Catalase (CAT) values close to the corresponding values of healthy ones. <b>Conclusion:</b> In conclusion, synthetic zeolite exhibits multi-health benefits with promising potentials against STZ-induced diabetes, this behaviour may be attributed to its antioxidant and free radical scavenging mechanisms.

Substituent enhanced fluorescence properties of star α-cyanostilbenes and their application in bioimaging.

A series of star α-cyanostilbenes with D-π-A structures comprising triphenylamine as the donor, the cyanovinyl group as the acceptor and different substituents on the terminal phenyl rings were synthesized and characterized. The influence of the substituents on the photophysical, electrochemical and thermal properties of the star molecules was investigated in detail. A strongly electron withdrawing nitro substituent on the phenyl ring (NTBTNPA) increased the absorption and emission maxima, the Stokes shift, and the difference between the ground and excited state dipole moments and decreased the fluorescence quantum yield, fluorescence lifetime and band gap energy between the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO). This molecule (i.e., NTBTNPA) also showed aggregation-induced enhanced emission; it showed emission at 608 nm in pure DMF and displayed red-shifted emission at 625 nm and new emission at 706 nm in a DMF/water (50 : 50) binary mixture. Aggregation of this molecule in different DMF/water mixtures was confirmed by the dynamic light scattering method. The HOMO, LUMO and band gap energy values of all the star molecules calculated theoretically using density functional theory (DFT) were in good agreement with the experimentally determined values. The biocompatibility of NTBTNPA was tested with two Gram positive and two Gram negative bacteria and also with a fungus. Based on the photophysical properties, NTBTNPA was used as a fluorophore for bio-imaging application of a fungus, Rhizoctonia solani, as a model and the results obtained were excellent.

Crystal structure of phenyl N-(3,5-di-methyl-phenyl)carbamate.

The asymmetric unit of the title compound, C15H15NO2, contains two independent mol-ecules (A and B). The di-methyl-phenyl ring, the phenyl ring and the central carbamate N-C(=O)-O group are not coplanar. In mol-ecule A, the di-methyl-phenyl and phenyl rings are inclined to the carbamate group mean plane by 27.71 (13) and 71.70 (4)°, respectively, and to one another by 84.53 (13)°. The corresponding dihedral angles in mol-ecule B are 34.33 (11), 66.32 (13) and 85.48 (12)°, respectively. In the crystal, the A and B mol-ecules are arranged alternately linked through N-H⋯O(carbon-yl) hydrogen bonds, forming -A-B-A-B- chains, which extend along [100]. Within the chains and linking neighbouring chains there are C-H⋯π inter-actions present, forming columns along the a-axis direction. The columns are linked by offset π-π stacking inter-actions, forming a three-dimensional network [shortest centroid-centroid distance = 3.606 (1) Å].

Crystal structures of 4-chloro-phenyl N-(3,5-di-nitro-phen-yl)carbamate and phenyl N-(3,5-di-nitro-phen-yl)carbamate.

The title compounds, C13H8ClN3O6, (I), and C13H9N3O6, (II), differ in the orientation of the two aromatic rings. In (I), they are essentially coplanar, making a dihedral angle of 8.2 (1)°, while in (II), they are inclined to one another by 76.2 (1)°. The two nitro groups are essentially coplanar with the attached benzene rings, as indicated by the dihedral angles of 1.4 (2) and 2.3 (2)° in (I), and 4.96 (18) and 5.4 (2)° in (II). The carbamate group is twisted slightly from the attached benzene ring, with a C-N-C-O torsion angle of -170.17 (15)° for (I) and 168.91 (13)° for (II). In the crystals of of both compounds, mol-ecules are linked via N-H⋯O hydrogen bonds, forming chains propagating along [010]. In (I), C-H⋯O hydrogen bonds also link mol-ecules within the chains. The crystal packing in (I) also features a very weak π-π inter-action [centroid-centroid distance = 3.7519 (9) Å].

Crystal structure of phenyl N-(4-nitro-phen-yl)carbamate.

The asymmetric unit of the title compound, C13H10N2O4, contains two independent mol-ecules (A and B). The dihedral angle between the aromatic rings is 48.18 (14)° in mol-ecule A and 45.81 (14)° in mol-ecule B. The mean plane of the carbamate N-C(=O)-O group is twisted slightly from the attached benzene and phenyl rings, making respective dihedral angles of 12.97 (13) and 60.93 (14)° in A, and 23.11 (14) and 59.10 (14)° in B. In the crystal, A and B mol-ecules are arranged alternately through N-H⋯O hydrogen bonds and C-H⋯π inter-actions, forming chains along the a axis. The chains are further linked by C-H⋯O hydrogen bonds into a double-chain structure.

Dose delivery accuracy of therapeutic photon and electron beams at low monitor unit settings.

PURPOSE: Dose delivery accuracy at low monitor units (LMU) was evaluated for photon and electron beams. Knowledge of this study is required for few dosimetric applications and to know the dose delivered to the patient when the treatment is delivered with few monitor units (MU). MATERIAL AND METHODS: Dose measurements were carried out for photon and electron beams with 0.6 cm(3) PTW ion chamber in white polystyrene phantom at D(max) with a field size of 10 x 10 cm(2) at 100 cm FSD. The relative dose, which is the ratio of dose delivered per MU at the testing to that of the calibration condition, was found out. RESULTS: Significant deviation (+20% to +25%) in dose delivery was noticed for photon and electron beams (+39% to +45%) at LMU settings. Slightly higher inaccuracy in dose delivery was noticed for 6-MV compared to 18-MV photons. The deviation in dose delivery for electron beams was found to be energy-independent and the pattern of variation was similar for all electron energies. CONCLUSION: The dose delivery accuracy at LMU settings has to be ascertained before implementing conformal and IMRT (intensity- modulated radiotherapy) techniques. When there is dose nonlinearity, the treatment delivered with multiple small MU settings can result in significant error in dose delivery.